GBS-6
- Generic Name
- GBS-6
Clinical Trial Investigating the Safety and Immunogenicity of GBS6 in Pregnant Women With and Without HIV (PREPARE)
Phase 2
Active, not recruiting
- Conditions
- Group B Streptococcal Infection
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-04-27
- Last Posted Date
- 2024-02-16
- Lead Sponsor
- St George's, University of London
- Target Recruit Count
- 300
- Registration Number
- NCT05832502
- Locations
- 🇺🇬
Makerere University, John Hopkins University, Kawempe, Uganda
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath